Vanderver Adeline
Department of Neurology, Children's National Medical Center, 111 Michigan Avenue, NW, Washington, DC 20010, USA.
Curr Neurol Neurosci Rep. 2005 Mar;5(2):110-8. doi: 10.1007/s11910-005-0008-1.
Advances in biochemical techniques, molecular genetics, and neuroimaging, particularly magnetic resonance imaging, have made possible the diagnosis of a significant proportion of leukodystrophies. A specific diagnosis allows the physician to give prognostic information, monitor for known complications, and ultimately may allow disease specific therapeutics. The purpose of this review is to familiarize the reader with pertinent tools in the diagnosis of leukodystrophies and other white matter disorders that may present with white matter disease. The first section discusses conditions that may mimic leukodystrophy and how to exclude them. Although not meant to be an exhaustive summary, several key disorders and their clinical, biochemical, and neuroimaging features are presented. The second section focuses on classically described leukodystrophies and their diagnosis. Finally, a third section provides a diagnostic algorithm to help the clinician in the diagnosis of the patient with leukodystrophy.
生物化学技术、分子遗传学以及神经影像学(尤其是磁共振成像)的进展,使得相当一部分脑白质营养不良症得以诊断。明确的诊断能让医生提供预后信息、监测已知并发症,最终或许还能采用针对特定疾病的治疗方法。本综述的目的是让读者熟悉诊断脑白质营养不良症及其他可能表现为白质病变的白质疾病的相关工具。第一部分讨论了可能与脑白质营养不良症相似的病症以及如何排除它们。虽然并非详尽无遗的总结,但列出了几种关键疾病及其临床、生化和神经影像学特征。第二部分聚焦于经典描述的脑白质营养不良症及其诊断。最后,第三部分提供了一种诊断算法,以帮助临床医生诊断脑白质营养不良症患者。